Free Trial

Tevogen Bio (TVGN) Competitors

Tevogen Bio logo
$0.87 -0.01 (-1.39%)
Closing price 04:00 PM Eastern
Extended Trading
$0.87 0.00 (-0.29%)
As of 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TVGN vs. TYRA, GOSS, PROK, DNA, BCAX, SNDL, SEPN, SVRA, MRVI, and ORGO

Should you be buying Tevogen Bio stock or one of its competitors? The main competitors of Tevogen Bio include Tyra Biosciences (TYRA), Gossamer Bio (GOSS), ProKidney (PROK), Ginkgo Bioworks (DNA), Bicara Therapeutics (BCAX), SNDL (SNDL), Septerna (SEPN), Savara (SVRA), Maravai LifeSciences (MRVI), and Organogenesis (ORGO). These companies are all part of the "pharmaceutical products" industry.

Tevogen Bio vs. Its Competitors

Tevogen Bio (NASDAQ:TVGN) and Tyra Biosciences (NASDAQ:TYRA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings.

In the previous week, Tevogen Bio had 1 more articles in the media than Tyra Biosciences. MarketBeat recorded 11 mentions for Tevogen Bio and 10 mentions for Tyra Biosciences. Tyra Biosciences' average media sentiment score of 1.10 beat Tevogen Bio's score of 0.62 indicating that Tyra Biosciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tevogen Bio
1 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tyra Biosciences
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

84.1% of Tyra Biosciences shares are owned by institutional investors. 73.2% of Tevogen Bio shares are owned by company insiders. Comparatively, 15.2% of Tyra Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tevogen BioN/AN/A-$13.73MN/AN/A
Tyra BiosciencesN/AN/A-$86.48M-$1.78-6.69

Tevogen Bio's return on equity of 0.00% beat Tyra Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Tevogen BioN/A N/A -775.49%
Tyra Biosciences N/A -31.22%-29.49%

Tevogen Bio has a beta of -0.78, suggesting that its stock price is 178% less volatile than the S&P 500. Comparatively, Tyra Biosciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.

Tevogen Bio presently has a consensus price target of $10.00, suggesting a potential upside of 1,046.13%. Tyra Biosciences has a consensus price target of $31.86, suggesting a potential upside of 167.48%. Given Tevogen Bio's higher probable upside, research analysts clearly believe Tevogen Bio is more favorable than Tyra Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tevogen Bio
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tyra Biosciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14

Summary

Tyra Biosciences beats Tevogen Bio on 7 of the 12 factors compared between the two stocks.

Get Tevogen Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TVGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TVGN vs. The Competition

MetricTevogen BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$174.04M$3.15B$5.78B$10.04B
Dividend YieldN/A2.28%5.27%4.52%
P/E RatioN/A21.4475.5726.08
Price / SalesN/A427.98516.51171.66
Price / CashN/A45.5837.2059.76
Price / Book-9.699.6011.536.20
Net Income-$13.73M-$53.33M$3.29B$270.65M
7 Day Performance-1.97%0.61%0.44%2.77%
1 Month Performance-3.11%11.11%10.84%8.83%
1 Year Performance95.50%12.61%61.62%27.49%

Tevogen Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TVGN
Tevogen Bio
3.3817 of 5 stars
$0.87
-1.4%
$10.00
+1,046.1%
+111.3%$174.04MN/A0.003
TYRA
Tyra Biosciences
2.8472 of 5 stars
$12.13
-4.1%
$31.43
+159.1%
-45.0%$674.21MN/A-6.8120Positive News
Analyst Forecast
Gap Up
GOSS
Gossamer Bio
3.8896 of 5 stars
$2.66
-9.5%
$8.50
+219.5%
+197.8%$668.50M$114.70M-4.29180News Coverage
Options Volume
Gap Up
PROK
ProKidney
3.2293 of 5 stars
$2.16
-4.0%
$6.25
+189.4%
-7.5%$662.14M$80K-3.793
DNA
Ginkgo Bioworks
1.8246 of 5 stars
$11.19
+0.3%
$9.50
-15.1%
+100.0%$660.08M$227.04M-1.91640Positive News
BCAX
Bicara Therapeutics
N/A$12.29
+1.9%
$32.25
+162.4%
N/A$658.03MN/A-3.8832Positive News
SNDL
SNDL
3.4344 of 5 stars
$2.39
-3.6%
$4.50
+88.3%
+14.7%$651.68M$671.81M-8.852,516
SEPN
Septerna
1.9433 of 5 stars
$14.67
+1.7%
$26.75
+82.3%
N/A$643.36M$1.08M-1.45N/A
SVRA
Savara
3.2433 of 5 stars
$3.85
+3.5%
$7.00
+81.8%
-10.3%$642.95MN/A-7.7020Trending News
Analyst Forecast
MRVI
Maravai LifeSciences
3.6128 of 5 stars
$2.44
-2.8%
$5.22
+113.9%
-70.0%$640.96M$259.18M-1.79610Positive News
ORGO
Organogenesis
3.9774 of 5 stars
$4.77
-4.6%
$7.50
+57.2%
+92.5%$634.29M$482.04M-34.07950News Coverage
Positive News
Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:TVGN) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners